LymphedemaV1, France, Analysis, bibRecord, 000317

[Unilateral acneiform rash in facial palsy].

Identifieur interne : 000317 ( France/Analysis ); précédent : 000316; suivant : 000318

[Unilateral acneiform rash in facial palsy].

Auteurs : D. Kerob [France] ; V. Hennequin ; G. Bousquet ; E. Behm ; C. Lebbe

Source :

Annales de dermatologie et de venereologie [ 0151-9638 ] ; 2010.

RBID : pubmed:21074658

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Anticorps monoclonaux (administration et posologie), Anticorps monoclonaux (effets indésirables), Anticorps monoclonaux humanisés, Antinéoplasiques (administration et posologie), Antinéoplasiques (effets indésirables), Carcinome épidermoïde (), Carcinome épidermoïde (traitement médicamenteux), Cétuximab, Humains, Mâle, Paralysie faciale (étiologie), Tumeurs de la parotide (), Tumeurs de la parotide (traitement médicamenteux), Éruptions acnéiformes ().
MESH :
- administration et posologie : Anticorps monoclonaux, Antinéoplasiques.
- effets indésirables : Anticorps monoclonaux, Antinéoplasiques.
- traitement médicamenteux : Carcinome épidermoïde, Tumeurs de la parotide.
- étiologie : Paralysie faciale.
- Adulte d'âge moyen, Anticorps monoclonaux humanisés, Carcinome épidermoïde, Cétuximab, Humains, Mâle, Tumeurs de la parotide, Éruptions acnéiformes.

English descriptors

KwdEn :
- Acneiform Eruptions (chemically induced), Antibodies, Monoclonal (administration & dosage), Antibodies, Monoclonal (adverse effects), Antibodies, Monoclonal, Humanized, Antineoplastic Agents (administration & dosage), Antineoplastic Agents (adverse effects), Carcinoma, Squamous Cell (complications), Carcinoma, Squamous Cell (drug therapy), Cetuximab, Facial Paralysis (etiology), Humans, Male, Middle Aged, Parotid Neoplasms (complications), Parotid Neoplasms (drug therapy).
MESH :
- chemical , administration & dosage : Antibodies, Monoclonal, Antineoplastic Agents.
- chemical , adverse effects : Antibodies, Monoclonal, Antineoplastic Agents.
- chemically induced : Acneiform Eruptions.
- complications : Carcinoma, Squamous Cell, Parotid Neoplasms.
- drug therapy : Carcinoma, Squamous Cell, Parotid Neoplasms.
- etiology : Facial Paralysis.
- chemical : Antibodies, Monoclonal, Humanized, Cetuximab, Humans, Male, Middle Aged.

Abstract

Cetuximab is a chimeric monoclonal antibody selective for epidermal growth factor receptor (EGFR). It is increasingly used in epithelial cancer, often in combination with radiotherapy or chemotherapeutic agents, since it induces a broad range of cellular responses that enhance tumour sensitivity to these therapies. However, it can cause numerous adverse effects, the most common being acneiform eruption on the face and trunk, which is generally bilateral and symmetric.

DOI: 10.1016/j.annder.2010.06.026
PubMed: 21074658

Affiliations:

Links to Exploration step

pubmed:21074658

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Unilateral acneiform rash in facial palsy].</title>
<author><name sortKey="Kerob, D" sort="Kerob, D" uniqKey="Kerob D" first="D" last="Kerob">D. Kerob</name>
<affiliation wicri:level="3"><nlm:affiliation>Hôpital Saint-Louis, AP-HP, Paris, France. delphine.kerob@sls.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Saint-Louis, AP-HP, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hennequin, V" sort="Hennequin, V" uniqKey="Hennequin V" first="V" last="Hennequin">V. Hennequin</name>
</author>
<author><name sortKey="Bousquet, G" sort="Bousquet, G" uniqKey="Bousquet G" first="G" last="Bousquet">G. Bousquet</name>
</author>
<author><name sortKey="Behm, E" sort="Behm, E" uniqKey="Behm E" first="E" last="Behm">E. Behm</name>
</author>
<author><name sortKey="Lebbe, C" sort="Lebbe, C" uniqKey="Lebbe C" first="C" last="Lebbe">C. Lebbe</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21074658</idno>
<idno type="pmid">21074658</idno>
<idno type="doi">10.1016/j.annder.2010.06.026</idno>
<idno type="wicri:Area/PubMed/Corpus">002847</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002847</idno>
<idno type="wicri:Area/PubMed/Curation">002847</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002847</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002847</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002847</idno>
<idno type="wicri:Area/Ncbi/Merge">003F58</idno>
<idno type="wicri:Area/Ncbi/Curation">003F58</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F58</idno>
<idno type="wicri:doubleKey">0151-9638:2010:Kerob D:unilateral:acneiform:rash</idno>
<idno type="wicri:Area/Main/Merge">005525</idno>
<idno type="wicri:Area/Main/Curation">005478</idno>
<idno type="wicri:Area/Main/Exploration">005478</idno>
<idno type="wicri:Area/France/Extraction">000317</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Unilateral acneiform rash in facial palsy].</title>
<author><name sortKey="Kerob, D" sort="Kerob, D" uniqKey="Kerob D" first="D" last="Kerob">D. Kerob</name>
<affiliation wicri:level="3"><nlm:affiliation>Hôpital Saint-Louis, AP-HP, Paris, France. delphine.kerob@sls.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Saint-Louis, AP-HP, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hennequin, V" sort="Hennequin, V" uniqKey="Hennequin V" first="V" last="Hennequin">V. Hennequin</name>
</author>
<author><name sortKey="Bousquet, G" sort="Bousquet, G" uniqKey="Bousquet G" first="G" last="Bousquet">G. Bousquet</name>
</author>
<author><name sortKey="Behm, E" sort="Behm, E" uniqKey="Behm E" first="E" last="Behm">E. Behm</name>
</author>
<author><name sortKey="Lebbe, C" sort="Lebbe, C" uniqKey="Lebbe C" first="C" last="Lebbe">C. Lebbe</name>
</author>
</analytic>
<series><title level="j">Annales de dermatologie et de venereologie</title>
<idno type="ISSN">0151-9638</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acneiform Eruptions (chemically induced)</term>
<term>Antibodies, Monoclonal (administration & dosage)</term>
<term>Antibodies, Monoclonal (adverse effects)</term>
<term>Antibodies, Monoclonal, Humanized</term>
<term>Antineoplastic Agents (administration & dosage)</term>
<term>Antineoplastic Agents (adverse effects)</term>
<term>Carcinoma, Squamous Cell (complications)</term>
<term>Carcinoma, Squamous Cell (drug therapy)</term>
<term>Cetuximab</term>
<term>Facial Paralysis (etiology)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parotid Neoplasms (complications)</term>
<term>Parotid Neoplasms (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Anticorps monoclonaux (administration et posologie)</term>
<term>Anticorps monoclonaux (effets indésirables)</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Antinéoplasiques (administration et posologie)</term>
<term>Antinéoplasiques (effets indésirables)</term>
<term>Carcinome épidermoïde ()</term>
<term>Carcinome épidermoïde (traitement médicamenteux)</term>
<term>Cétuximab</term>
<term>Humains</term>
<term>Mâle</term>
<term>Paralysie faciale (étiologie)</term>
<term>Tumeurs de la parotide ()</term>
<term>Tumeurs de la parotide (traitement médicamenteux)</term>
<term>Éruptions acnéiformes ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticorps monoclonaux</term>
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Acneiform Eruptions</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Parotid Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term>
<term>Parotid Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anticorps monoclonaux</term>
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Facial Paralysis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinome épidermoïde</term>
<term>Tumeurs de la parotide</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Paralysie faciale</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Cetuximab</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Carcinome épidermoïde</term>
<term>Cétuximab</term>
<term>Humains</term>
<term>Mâle</term>
<term>Tumeurs de la parotide</term>
<term>Éruptions acnéiformes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Cetuximab is a chimeric monoclonal antibody selective for epidermal growth factor receptor (EGFR). It is increasingly used in epithelial cancer, often in combination with radiotherapy or chemotherapeutic agents, since it induces a broad range of cellular responses that enhance tumour sensitivity to these therapies. However, it can cause numerous adverse effects, the most common being acneiform eruption on the face and trunk, which is generally bilateral and symmetric.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Behm, E" sort="Behm, E" uniqKey="Behm E" first="E" last="Behm">E. Behm</name>
<name sortKey="Bousquet, G" sort="Bousquet, G" uniqKey="Bousquet G" first="G" last="Bousquet">G. Bousquet</name>
<name sortKey="Hennequin, V" sort="Hennequin, V" uniqKey="Hennequin V" first="V" last="Hennequin">V. Hennequin</name>
<name sortKey="Lebbe, C" sort="Lebbe, C" uniqKey="Lebbe C" first="C" last="Lebbe">C. Lebbe</name>
</noCountry>
<country name="France"><region name="Île-de-France"><name sortKey="Kerob, D" sort="Kerob, D" uniqKey="Kerob D" first="D" last="Kerob">D. Kerob</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000317 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000317 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:21074658
   |texte=   [Unilateral acneiform rash in facial palsy].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:21074658" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

[Unilateral acneiform rash in facial palsy].

[Unilateral acneiform rash in facial palsy].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.